Insulin activation of plasma nonesterified fatty acid uptake in metabolic syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 8, 2012, Pages 1799-1808

  Ramos Roman, Maria A ^a   Lapidot, Smadar A ^b   Phair, Robert D ^b   Parks, Elizabeth J ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Integrative Bioinformatics Inc   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

insulin; kinetics; mathematical modeling; nonesterified fatty acids; regulation

Indexed keywords

FATTY ACID; INSULIN;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATION; PRIORITY JOURNAL;

ADULT; AGED; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84864289240     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.250019     Document Type: Article

References (46)

1. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236:E667-E677. (Pubitemid 9220487)
2. Bergman RN. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes. 2007;56:1489-1501. (Pubitemid 46842592)
3. Periwal V, Chow CC, Bergman RN, Ricks M, Vega GL, Sumner AE. Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1089-R1096.
4. Jelic K, Hallgreen CE, Colding-Jørgensen M. A model of NEFA dynamics with focus on the postprandial state. Ann Biomed Eng. 2009;37:1897-1909.
5. Boston RC, Moate PJ. A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1140-R1147. (Pubitemid 351490632)
6. Chow CC, Periwal V, Csako G, Ricks M, Courville AB, Miller BV 3rd, Vega GL, Sumner AE. Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women. J Clin Endocrinol Metab. 2011;96:2456-2463.
7. Carpentier AC, Frisch F, Brassard P, Lavoie F, Bourbonnais A, Cyr D, Giguère R, Baillargeon JP. Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. Am J Physiol Endocrinol Metab. 2007;292:E693-E701. (Pubitemid 46411045)
8. Frayn KN. Metabolic Regulation: A Human Perspective. 2nd ed. Oxford, United Kingdom: Oxford Blackwell; 2003:339-340.
9. Stump DD, Fan X, Berk PD. Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake. J Lipid Res. 2001;42:509-520. (Pubitemid 32366993)
10. Nestel PJ, Ishikawa T, Goldrick RB. Diminished plasma free fatty acid clearance in obese subjects. Metab Clin Exp. 1978;27:589-597. (Pubitemid 8328998)
11. Shadid S, Kanaley JA, Sheehan MT, Jensen MD. Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab. 2007;292:E1770-E1774. (Pubitemid 47084712)
12. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes. 2003;52:1641-1648. (Pubitemid 36792451)
13. Eaton RP, Berman M, Steinberg D. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J Clin Invest. 1969;48:1560-1579.
14. Taskinen MR, Bogardus C, Kennedy A, Howard BV. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy. J Clin Invest. 1985;76:637-644. (Pubitemid 15227528)
15. Stahl A, Evans JG, Pattel S, Hirsch D, Lodish HF. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell. 2002;2:477-488. (Pubitemid 34436575)
16. Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JF, Luiken JJ, Bonen A. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett. 2009;583:2294-2300.
17. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ, Glatz JF. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol. 1998;275(3 Pt 1): E471-E478.
18. Glatz JF, Luiken JJ, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev. 2010;90:367-417.
19. Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011;14:804-810.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2006;21:1-6. (Pubitemid 43194325)
21. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest. 1999;104:1087-1096. (Pubitemid 29536319)
22. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5:1003-1015. (Pubitemid 38009940)
23. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab. 2006;91:1446-1452.
24. Ramos-Roman MA, Sweetman L, Valdez MJ, Parks EJ. Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity. Metab Clin Exp. 2012;61:202-212.
25. Phair RD. Development of kinetic models in the nonlinear world of molecular cell biology. Metab Clin Exp. 1997;46:1489-1495. (Pubitemid 28053219)
26. Phair RD, Misteli T. Kinetic modelling approaches to in vivo imaging. Nat Rev Mol Cell Biol. 2001;2:898-907. (Pubitemid 33674089)
27. Cobelli C, Foster DM. Compartmental models: theory and practice using the SAAM II software system. Adv Exp Med Biol. 1998;445:79-101. (Pubitemid 28391767)
28. Cirit M, Haugh JM. Quantitative models of signal transduction networks: how detailed should they be? Commun Integr Biol. 2011;4:353-356.
29. Beard DA, Kushmerick MJ. Strong inference for systems biology. PLoS Comput Biol. 2009;5:e1000459.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
31. Salgado AL, Carvalho L, Oliveira AC, Santos VN, Vieira JG, Parise ER. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arq Gastroenterol. 2010;47:165-169.
32. Coppack SW, Fisher RM, Gibbons GF, Humphreys SM, McDonough MJ, Potts JL, Frayn KN. Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci. 1990;79:339-348. (Pubitemid 20331470)
33. Evans K, Clark ML, Frayn KN. Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism. Am J Physiol. 1999;276(2 Pt 1):E241-E248. (Pubitemid 29100578)
34. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkänen L, Karter AJ, Hamman R, Saad MF. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63-69. (Pubitemid 27009951)
35. Barrett PH, Chan DC, Watts GF. Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans. J Lipid Res. 2006;47:1607-1619. (Pubitemid 44222813)
36. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res. 2002;43:223-233. (Pubitemid 34184009)
37. Roy A, Parker RS. Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model". Diabetes Technol Ther. 2006;8:617-626. (Pubitemid 44871491)
38. Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R. A model of the kinetics of insulin in man. J Clin Invest. 1974;53:1481-1492.
39. Goldberg IJ, Eckel RH, Abumrad NA. Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways. J Lipid Res. 2009;50 Suppl:S86-S90.
40. Bell JA, Reed MA, Consitt LA, Martin OJ, Haynie KR, Hulver MW, Muoio DM, Dohm GL. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. J Clin Endocrinol Metab. 2010;95:3400-3410.
41. Yee AJ, Turcotte LP. Insulin fails to alter plasma LCFA metabolism in muscle perfused at similar glucose uptake. Am J Physiol Endocrinol Metab. 2002;283:E73-E77. (Pubitemid 34686670)
42. Caruso M, Divertie GD, Jensen MD, Miles JM. Lack of effect of hyperglycemia on lipolysis in humans. Am J Physiol. 1990;259(4 Pt 1):E542-E547. (Pubitemid 20340372)
43. Summers LK, Samra JS, Frayn KN. Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? Atherosclerosis. 1999;147:11-15. (Pubitemid 29486767)
44. Labbé SM, Croteau E, Grenier-Larouche T, Frisch F, Ouellet R, Langlois R, Guérin B, Turcotte EE, Carpentier AC. Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes. Diabetes. 2011;60:408-415.
45. Prager R, Wallace P, Olefsky JM. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986;78:472-481. (Pubitemid 16074085)
46. Boston RC, Moate PJ. NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test. Am J Physiol Regul Integr Comp Physiol. 2008;295:R395-R403.